Context Therapeutics Inc. CNTX
0.35
(0.02)
(5.41%)
as of 25 Sep
- Market cap
- $34.1M
- P/E
- 0.0×
Follow CNTX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (76.14%) | (56.19%) | (46.39%) | (33.68%) |
+8 more TTM periods Free account |
|
| (68.96%) | (52.99%) | (43.36%) | (31.94%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(120.91%) | (77.29%) | (59.84%) | (36.19%) | |
Free Cash Flow per Share |
(0.36) | (0.34) | (0.28) | (0.24) | |
Free Cash Flow |
(34.03) | (32.82) | (26.42) | (22.38) | |
Capital Expenditures |
(0.06) | (0.04) | (0.03) | (0.03) | |
| Other line items | |||||
Cash ROIC |
(41.86%) | (30.72%) | (20.86%) | (14.89%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.74 | 0.82 | 0.73 | 0.85 | |
Depreciation/Fixed assets |
0.26 | 0.27 | 0.55 | 0.45 | |
Capex/Depreciation |
(2.86) | (2.21) | (2.08) | (2.23) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.36) | (0.34) | (0.28) | (0.23) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates